The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of Guideline

dc.contributor.author
Fountoulakis, Konstantinos N.
dc.contributor.author
Young, Allan H.
dc.contributor.author
Yatham, Lakshmi
dc.contributor.author
Grunze, Heinz
dc.contributor.author
Vieta i Pascual, Eduard, 1963-
dc.contributor.author
Blier, Pierre
dc.contributor.author
Moeller, Hans J.
dc.contributor.author
Kasper, Siegfried
dc.date.issued
2017-10-06T08:25:37Z
dc.date.issued
2017-10-06T08:25:37Z
dc.date.issued
2016-11-04
dc.identifier
1461-1457
dc.identifier
https://hdl.handle.net/2445/116263
dc.identifier
665158
dc.identifier
27815414
dc.description.abstract
Podeu consultar la part 2: http://hdl.handle.net/2445/116264
dc.description.abstract
Podeu consultar la part 3: http://hdl.handle.net/2445/116265
dc.description.abstract
Podeu consultar la part 4: http://hdl.handle.net/2445/116267
dc.description.abstract
Background: This paper includes a short description of the important clinical aspects of Bipolar Disorder with emphasis on issues that are important for the therapeutic considerations, including mixed and psychotic features, predominant polarity, and rapid cycling as well as comorbidity. Methods: The workgroup performed a review and critical analysis of the literature concerning grading methods and methods for the development of guidelines. Results: The workgroup arrived at a consensus to base the development of the guideline on randomized controlled trials and related meta-analyses alone in order to follow a strict evidence-based approach. A critical analysis of the existing methods for the grading of treatment options was followed by the development of a new grading method to arrive at efficacy and recommendation levels after the analysis of 32 distinct scenarios of available data for a given treatment option. Conclusion: The current paper reports details on the design, method, and process for the development of CINP guidelines for the treatment of Bipolar Disorder. The rationale and the method with which all data and opinions are combined in order to produce an evidence-based operationalized but also user-friendly guideline and a specific algorithm are described in detail in this paper.
dc.format
23 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
Oxford University Press
dc.relation
Reproducció del document publicat a: http://doi.org/10.1093/ijnp/pyw091
dc.relation
International Journal of Neuropsychopharmacology, 2017, vol. 20, num. 2, p. 98-120
dc.relation
http://doi.org/10.1093/ijnp/pyw091
dc.relation
http://hdl.handle.net/2445/116264
dc.relation
http://hdl.handle.net/2445/116265
dc.relation
http://hdl.handle.net/2445/116267
dc.rights
cc-by-nc (c) Fountoulakis, Konstantinos N. et al., 2017
dc.rights
http://creativecommons.org/licenses/by-nc/3.0/es
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Medicina)
dc.subject
Trastorn bipolar
dc.subject
Adults
dc.subject
Farmacologia
dc.subject
Manic-depressive illness
dc.subject
Methodology
dc.subject
Adulthood
dc.subject
Pharmacology
dc.title
The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of Guideline
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)